A2 Biotherapeutics Presents Data from EVEREST-2 Study, Including First Report of a Complete Response to CAR T-Cell Therapy in ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

First presentation of U.S. IDE clinical data shows statistically significant improvements in pain and function at 24 months ...

Nurix Therapeutics (NRIX) announced the presentation of new translational data from its ongoing Phase 1 study of NX-1607, an oral, first-in-class ...

Iain Cheeseman and colleagues reveal the underappreciated role of single genes producing multiple proteins in atypical ...

Iain Cheeseman and colleagues reveal the underappreciated role of single genes producing multiple proteins in atypical presentations of rare disease, and present case studies of affected patients ...

In contrast, by utilizing technology-driven tools more effectively, we can drive efficiencies, improve communication, and ...

A new study recommends Michigan should centralize revenue collected in trial courts to remove pressures causing some judges to over-bill defendants.

Day one focused on the implementation of ETINED’s Terms of Reference, recent developments in the Council of Europe’s ...

Allogene Therapeutics, Inc. downgraded to Hold after ALPHA3 trial setbacks. Review updated pipeline prospects and risks.

A win-odds analysis is a statistical method used to analyze clinical trial data to evaluate the effectiveness of treatments. It provides a novel way to measure treatment effect by comparing the number ...

"It is truly a case of things returning to their rightful place." On November 3, Kim Jeongsu, Vice Chairman of Samyang Foods, ...